News

Bold Insight and MedRhythms to present on digital therapeutics design at DTx West

February 22, 2022

Bold Insight’s Jackie Ulaszek and Allison Paul will participate alongside Sarah Cooper, Product Manager at MedRhythms, in a panel discussion, “Designing Digital Therapeutics around the Needs of the Patients” as part of the DTx West 2022 conference. The discussion will explore what it looks like to design digital therapeutics (DTx) around both patient needs and FDA regulations and guidance; they will touch on the partnerships and processes involved.

“Designing successful digital therapeutics calls for understanding of both patient needs and expectations and standards of the FDA,” says Jackie Ulaszek, Partner at Bold Insight. “This discussion will cover how to achieve a stellar patient experience in a regulated landscape and how to anticipate expectations of the FDA both in a validation study and ongoing development.”   

DTx West brings together leaders in the digital health space to discuss evolving trends and key insights in the digital therapeutics industry. The panel discussion will take place on Thursday, February 24, 2022, at 5:10 PM PST both online and in-person in San Mateo, CA. Learn more about the conference on the registration page.

Are you designing digital therapeutics solutions? Let us help!

The foundation for safe and effective use begins with exploratory research and spans the entire development process.

For press inquiries reach out to Pamela Stoffregen-Gay at press@boldinsight.com.